Cohen Joshua B
Insider CIK 1898644 · AMLX Co-Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2026-09-10 | 2026-09-14 | 29,545 | $32.16 | $950.2K | 3,614,042 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2026-09-10 | 2026-09-14 | 919 | $33.15 | $30.5K | 3,613,123 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2026-09-10 | 2026-09-14 | 919 | $33.15 | $30.5K | 3,613,123 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2026-09-10 | 2026-09-14 | 29,545 | $32.16 | $950.0K | 3,614,042 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award | 2026-08-18 | 2026-08-20 | 60,039 | — | $0 | 3,643,587 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award | 2026-08-18 | 2026-08-20 | 60,039 | — | $0 | 3,643,587 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award deriv | 2026-03-05 | 2026-03-09 | 373,295 | — | $0 | 373,295 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award | 2026-03-05 | 2026-03-09 | 248,865 | — | $0 | 3,583,548 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2026-03-02 | 2026-03-04 | 29,282 | $14.48 | $424.0K | 3,334,683 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2026-02-02 | 2026-02-04 | 15,500 | $14.68 | $227.5K | 3,363,965 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | M Exercise deriv | 2026-01-16 | 2026-01-20 | 2,818 | — | $0 | 0 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2026-01-16 | 2026-01-20 | 1,974 | $13.83 | $27.3K | 3,379,465 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | M Exercise | 2026-01-16 | 2026-01-20 | 2,818 | $7.57 | $21.3K | 3,381,439 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | M Exercise deriv | 2026-01-15 | 2026-01-20 | 197,182 | — | $0 | 2,818 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2026-01-15 | 2026-01-20 | 136,193 | $13.59 | $1.85M | 3,378,621 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | M Exercise | 2026-01-15 | 2026-01-20 | 197,182 | $7.57 | $1.49M | 3,514,814 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2026-01-06 | 2026-01-08 | 7,715 | $11.09 | $85.6K | 3,317,632 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2025-09-30 | 2025-10-02 | 200 | $15.00 | $3.0K | 3,325,347 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2025-09-30 | 2025-10-02 | 29,733 | $14.34 | $426.4K | 3,325,547 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2025-03-31 | 2025-04-02 | 21,490 | $3.47 | $74.6K | 3,355,280 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award deriv | 2025-03-06 | 2025-03-10 | 270,177 | — | $0 | 270,177 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award | 2025-03-06 | 2025-03-10 | 180,118 | — | $0 | 3,376,770 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2025-03-03 | 2025-03-05 | 4,595 | $3.17 | $14.6K | 3,196,652 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2025-02-03 | 2025-02-05 | 11,851 | $3.47 | $41.1K | 3,201,247 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2025-01-06 | 2025-01-08 | 7,471 | $4.05 | $30.3K | 3,213,098 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2024-09-30 | 2024-10-02 | 18,589 | $3.20 | $59.5K | 3,220,569 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | M Exercise deriv | 2024-09-23 | 2024-09-25 | 1,857 | — | $0 | 0 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | M Exercise | 2024-09-23 | 2024-09-25 | 1,857 | $1.57 | $2.9K | 3,239,158 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | M Exercise deriv | 2024-09-12 | 2024-09-16 | 34,449 | — | $0 | 1,857 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | M Exercise | 2024-09-12 | 2024-09-16 | 34,449 | $1.57 | $54.1K | 3,237,301 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award deriv | 2024-04-16 | 2024-04-18 | 380,000 | — | $0 | 380,000 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award | 2024-04-16 | 2024-04-18 | 179,850 | — | $0 | 3,202,852 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2024-03-05 | 2024-03-07 | 4,135 | $18.73 | $77.4K | 3,023,002 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award deriv | 2024-02-26 | 2024-02-28 | 190,000 | — | $0 | 190,000 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award | 2024-02-26 | 2024-02-28 | 126,667 | — | $0 | 3,027,137 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2024-01-09 | 2024-01-11 | 5,841 | $16.33 | $95.4K | 2,900,470 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | M Exercise deriv | 2023-11-16 | 2023-11-20 | 63,694 | — | $0 | 36,306 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | M Exercise | 2023-11-16 | 2023-11-20 | 63,694 | $1.57 | $100.0K | 2,906,311 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award deriv | 2023-03-16 | 2023-03-20 | 225,000 | — | $0 | 225,000 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2023-03-16 | 2023-03-20 | 3,924 | $32.45 | $127.3K | 2,792,617 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2023-03-16 | 2023-03-20 | 96,076 | $31.84 | $3.06M | 2,796,541 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award | 2023-03-16 | 2023-03-20 | 50,000 | — | $0 | 2,842,617 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2023-01-06 | 2023-01-10 | 1,846 | $36.79 | $67.9K | 2,892,617 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2023-01-06 | 2023-01-10 | 4,122 | $36.08 | $148.7K | 2,894,463 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | M Exercise deriv | 2022-05-05 | 2022-05-06 | 334,520 | — | $0 | 0 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | M Exercise | 2022-05-05 | 2022-05-06 | 334,520 | $0.37 | $123.8K | 2,898,585 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award deriv | 2022-01-06 | 2022-01-10 | 337,500 | — | $0 | 337,500 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | C Conversion deriv | 2022-01-06 | 2022-01-10 | 4,870 | — | $0 | 0 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | C Conversion | 2022-01-06 | 2022-01-10 | 4,870 | — | $0 | 2,489,065 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award | 2022-01-06 | 2022-01-10 | 75,000 | — | $0 | 2,564,065 | SEC↗ |